0001454263-22-000003.txt : 20220317 0001454263-22-000003.hdr.sgml : 20220317 20220317155050 ACCESSION NUMBER: 0001454263-22-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220317 DATE AS OF CHANGE: 20220317 EFFECTIVENESS DATE: 20220317 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STAGEZERO LIFE SCIENCES LTD. CENTRAL INDEX KEY: 0001454263 IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-437799 FILM NUMBER: 22748352 BUSINESS ADDRESS: STREET 1: 70 EAST BEAVER CREEK ROAD STREET 2: UNIT 30 CITY: RICHMOND HILL STATE: A6 ZIP: L4B 3B2 BUSINESS PHONE: 905-209-2030 MAIL ADDRESS: STREET 1: 70 EAST BEAVER CREEK ROAD STREET 2: UNIT 30 CITY: RICHMOND HILL STATE: A6 ZIP: L4B 3B2 FORMER COMPANY: FORMER CONFORMED NAME: GENENEWS LTD DATE OF NAME CHANGE: 20090116 D 1 primary_doc.xml X0708 D LIVE 0001454263 STAGEZERO LIFE SCIENCES LTD. 70 EAST BEAVER CREEK ROAD UNIT 30 RICHMOND HILL A6 ONTARIO, CANADA L4B 3B2 905-209-2030 ONTARIO, CANADA ChondroGene Limited Lewis Brook Resources Ltd. GENENEWS LTD Corporation true James R. Howard-Tripp 70 East Beaver Creek Road Unit 30 Richmond Hill A6 ONTARIO, CANADA L4B 3B2 Executive Officer Director Harry Glorikian 70 East Beaver Creek Road Unit 30 Richmond Hill A6 ONTARIO, CANADA L4B 3B2 Director Garth MacRae 70 East Beaver Creek Road Unit 30 Richmond Hill A6 ONTARIO, CANADA L4B 3B2 Director Richard Janice Huston 70 East Beaver Creek Road Unit 30 Richmond Hill A6 ONTARIO, CANADA L4B 3B2 Director Rory Riggs 70 East Beaver Creek Road Unit 30 Richmond Hill A6 ONTARIO, CANADA L4B 3B2 Director Biotechnology $5,000,001 - $25,000,000 06b false 2022-03-02 true true true true true Each unit consists of one common share and one transferable share purchase warrant. Each whole warrant is exercisable for one additional share until March 2, 2026 at Cdn$0.2206 per share. false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue 4th Floor New York NY NEW YORK 10022 NY NEW YORK false 3217557 1476161 1741396 The additional $1,741,396.00 may be received upon the exercise of share purchase warrants sold inside or outside the U.S. Dollar amounts are based on the Bank of Canada average rate of exchange reported on March 2, 2022, which wad Cdn$1.2668=USD$1.00. false 1 227882 0 Includes broker warrants to purchase 800,000 common shares of the issuer at Cdn$0.2206 per share for a period of 4 years. 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false STAGEZERO LIFE SCIENCES LTD. Matthew Pietras Matthew Peitras CFO & COO 2022-03-17